53 results on '"Geisbert, Thomas W."'
Search Results
2. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence between Angola and Ci67 strains
3. Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting
4. Limited benefit of post-exposure prophylaxis with VSV-EBOV in Ebola virus-infected rhesus macaques
5. Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody
6. Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona
7. A highly attenuated pan-filovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and three species of Ebolavirus
8. Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates
9. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity
10. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection
11. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys
12. An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green Monkeys
13. Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
14. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates
15. Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret (Mustela putorius furo)
16. Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms
17. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
18. Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood
19. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
20. Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
21. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
22. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
23. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
24. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species ofEbolavirus
25. Development of Prototype Filovirus Recombinant Antigen Immunoassays
26. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
27. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model
28. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
29. Modeling the Disease Course ofZaire ebolavirusInfection in the Outbred Guinea Pig
30. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus–Based Filovirus Vaccines
31. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs
32. Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats
33. Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
34. Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
35. A Recently Isolated Lassa Virus From Mali Demonstrates Atypical Clinical Disease Manifestations and Decreased Virulence in Cynomolgus Macaques
36. Pathogenesis of Marburg Hemorrhagic Fever in Cynomolgus Macaques
37. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
38. Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus
39. Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy
40. Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
41. Therapeutics of Ebola Hemorrhagic Fever: Whole-Genome Transcriptional Analysis of Successful Disease Mitigation
42. Lymphocyte Death in a Mouse Model of Ebola Virus Infection
43. In Vitro and In Vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein
44. Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2
45. Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever
46. Epitopes Required for Antibody‐Dependent Enhancement of Ebola Virus Infection
47. Pathologic Findings Associated with Delayed Death in Nonhuman Primates Experimentally Infected with Zaire Ebola Virus
48. Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
49. Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference
50. Microscopy in the Hot Zone: From the Discovery of Ebola Virus to a Possible Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.